Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil?

Urology Annals
Yasushi TanumaTomoshi Okamoto

Abstract

There have been reports that one of the factors affecting the efficacy of α1-adrenoceptor antagonists (α1-blocker; α1-B) was prostate volume (PV). However, there are few reports of short-term prospective trials comparing the efficacy of α1-B by PV. We examined the influence of PV on the short-term efficacy of naftopidil dose increase therapy to administration of 75 mg/day after an initial dose of 50 mg/day. A total of 85 patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) received 50 mg/day of naftopidil for 4 weeks. After 4 weeks, the dosage of naftopidil was increased to 75 mg/day for a further 4 weeks. We divided the patients into two groups of PV ≥40 mL at baseline (Group L) and PV <40 mL at baseline (Group S). International Prostate Symptom Score (IPSS), IPSS storage symptoms, and IPSS quality-of-life score were significantly improved at 4 and 8 weeks compared with baseline in both Groups. IPSS voiding symptoms (IPSS-VS) were significantly improved at 4 and 8 weeks compared with baseline in Group S. IPSS and IPSS-VS were significantly improved at 8 weeks compared with 4 weeks only in Group L. IPSS-VS and intermittency at 4 weeks were significantly decreased in Group S compared...Continue Reading

References

Mar 26, 2002·The Journal of Urology·Jean J M C H de la RosetteLambertus A L M Kiemeney
Jun 11, 2005·The Journal of Urology·Qin ChenTadaichi Kitamura
Aug 3, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Teruhiko YokoyamaToyohiko Watanabe
May 2, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Taiji TsukamotoMartin M Crane
Sep 14, 2007·Scandinavian Journal of Urology and Nephrology·Naoya MasumoriUNKNOWN The Sapporo Medical University Naftopidil Study Group
Mar 24, 2010·World Journal of Urology·Yasuhito FunahashiMomokazu Gotoh
Jul 29, 2010·Korean journal of urology·Kyoung Pyo HongWoo Sik Chung
Oct 22, 2010·Scandinavian Journal of Urology and Nephrology·Yoshiki KurizakiKarl-Erik Andersson
Jul 15, 2011·Therapeutics and Clinical Risk Management·Naoya Masumori
Nov 5, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Japanese Urological Association
Oct 20, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Satoshi YamaguchiHidehiro Kakizaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.